Ceftriaxone Sodium Injection, Powder, For Solution
Product Images NDC 67184-1007

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ceftriaxone Sodium (NDC 67184-1007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (01)

Chemical structure of Ceftriaxone Sodium. The diagram shows the detailed molecular arrangement including atoms and bonds, highlighting the sodium salt form with associated hydration (3.5 H2O).*

FDA Label Image

Ceftriaxone For Injection 250 mg Label (02)

Label of Ceftriaxone Sodium for Injection, USP, 250 mg per vial, injection powder for solution by Qilu Pharmaceutical Co., Ltd. The label specifies intramuscular or intravenous use, single-use vial, and includes dosage and storage instructions. Package label also shows the NDC code 67184-1005-1 and manufacturer details for Apotex Corp.*

FDA Label Image

Ceftriaxone For Injection 500 mg Label (03)

Ceftriaxone Sodium Injection, USP 500 mg per vial, powder for solution for intramuscular or intravenous use. The label states single-use vial packaging by Apotex Corp. It provides reconstitution instructions for IM and IV use, storage directions, and dosage information. Manufactured in China by Qilu Pharmaceutical Co., Ltd. for Apotex Corp., Weston, FL.*

FDA Label Image

Ceftriaxone For Injection 1 G Label (04)

Ceftriaxone Sodium Injection powder for solution label showing 1 g per vial strength. The label indicates intramuscular and intravenous use, single-use vial packaging, and is manufactured by Qilu Pharmaceutical Co., Ltd. The label includes reconstitution instructions and storage information, along with the labeler Apotex Corp.*

FDA Label Image

Ceftriaxone For Injection 2 G Label (05)

Label for Ceftriaxone Sodium Injection, USP 2 g per vial powder for solution. It is designed for intramuscular or intravenous use and supplied as a single-use vial. The label includes detailed reconstitution instructions, storage conditions, and manufacturer information for Qilu Pharmaceutical Co., Ltd., distributed by Apotex Corp.*

FDA Label Image

06

Packaging label for Ceftriaxone for Injection USP 250 mg/vial by Apotex Corp. The label includes dosing information for intramuscular and intravenous use, storage instructions, and a barcode. The label also notes it is Rx only and that the package contains 10 single-use vials of 250 mg strength powder for solution injection.*

FDA Label Image

07

Packaging label for Ceftriaxone for Injection USP 500 mg/vial, a powder for injection by intramuscular or intravenous use. The label shows it contains 10 single-use vials of 500 mg strength. Manufactured by Qilu Pharmaceutical Co., Ltd. and marketed by Apotex Corp. Instructions and storage information are included on the carton.*

FDA Label Image

08

Ceftriaxone for Injection, USP 250 mg per vial powder for solution, in single-use vials. The label indicates use for intramuscular or intravenous injection, manufactured by Qilu Pharmaceutical Co., Ltd., and distributed by Apotex Corp. The packaging specifies a 1 vial per package count and Rx only status.*

FDA Label Image

09

Label for Ceftriaxone for Injection, USP 500 mg/vial, an injection powder for solution indicated for intramuscular or intravenous use. The label states 1x500 mg single-use vials, Rx only, and lists Qilu Pharmaceutical Co., Ltd. as manufacturer and Apotex Corp. as manufacturer for the US. Directions for use and storage instructions are also included.*

FDA Label Image

10

Packaging label for Ceftriaxone for Injection, USP 1 g/vial, an injection powder for solution for intramuscular or intravenous use. The label includes directions for use, manufacturer details showing Qilu Pharmaceutical Co., Ltd. as the labeler and Apotex Corp. as the manufacturer, with packaging for 10 single-use vials. The label is primarily white with blue and black text and highlights the 1 g/vial strength in yellow boxes.*

FDA Label Image

11

Packaging label for Ceftriaxone for Injection, USP 2 g/vial as a powder for solution for injection. The label indicates use for intramuscular or intravenous administration, with Rx-only status. It is supplied by APOTEX CORP. in 10 x 2 g single-use vials. The manufacturer is Qilu Pharmaceutical Co., Ltd. The label includes product identifiers such as NDC 67184-1008-1 and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.